Literature DB >> 7915139

Modulation of P-glycoprotein by protein kinase C alpha in a baculovirus expression system.

S Ahmad1, A R Safa, R I Glazer.   

Abstract

The modulation of P-glycoprotein by protein kinase C alpha (PKC alpha) was examined in a baculovirus expression system. PGP was phosphorylated in membrane vesicle preparations in vitro only when coexpressed with PKC alpha, and phosphorylation was Ca(2+)-dependent and inhibited by the PKC inhibitor Ro 31-8220. PGP and PKC alpha were tightly associated in membrane vesicles and were coimmunoprecipitated with antibodies against either PGP or PKC alpha. Photoaffinity labeling of membrane vesicles with [3H]azidopine indicated that drug binding to PGP was slightly increased in the presence of PKC alpha. In contrast, PGP ATPase activity was increased by PKC alpha as well as by verapamil, but only PKC-stimulated activity in the presence of verapamil was inhibited by Ro 31-8220. Mutation of serine-671 to asparagine in the linker region of PGP abolished PKC alpha-stimulated ATPase activity, and also inhibited to a lesser degree verapamil-stimulated ATPase activity. These results indicate that PKC alpha in a positive regulator of PGP ATPase activity and suggest that this mechanism may account for the increased multidrug resistance observed in MDR1-expressing cells when PKC alpha activity is elevated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7915139     DOI: 10.1021/bi00200a011

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  17 in total

1.  Protein kinases and multidrug resistance.

Authors:  M G Rumsby; L Drew; J R Warr
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

Review 2.  Effects of phosphorylation of P-glycoprotein on multidrug resistance.

Authors:  U A Germann; T C Chambers; S V Ambudkar; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1995-02       Impact factor: 2.945

Review 3.  Regulation of volume-activated chloride channels by P-glycoprotein: phosphorylation has the final say!

Authors:  H T Idriss; Y A Hannun; E Boulpaep; S Basavappa
Journal:  J Physiol       Date:  2000-05-01       Impact factor: 5.182

Review 4.  Protein kinase C isozymes and substrates in mammary carcinogenesis.

Authors:  S C Kiley; J Welsh; C J Narvaez; S Jaken
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-04       Impact factor: 2.673

5.  Protein kinase C phosphorylation disengages human and mouse-1a P-glycoproteins from influencing the rate of activation of swelling-activated chloride currents.

Authors:  T D Bond; M A Valverde; C F Higgins
Journal:  J Physiol       Date:  1998-04-15       Impact factor: 5.182

6.  Evaluation of 2,6-diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl)- hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistance in vitro.

Authors:  E C Sha; M C Sha; S H Kaufmann
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

7.  Reversal of efflux of an anticancer drug in human drug-resistant breast cancer cells by inhibition of protein kinase Cα (PKCα) activity.

Authors:  Chan Woo Kim; Daisuke Asai; Jeong-Hun Kang; Akihiro Kishimura; Takeshi Mori; Yoshiki Katayama
Journal:  Tumour Biol       Date:  2015-09-02

8.  Interrogation of multidrug resistance (MDR1) P-glycoprotein (ABCB1) expression in human pancreatic carcinoma cells: correlation of 99mTc-Sestamibi uptake with western blot analysis.

Authors:  Scott E Harpstrite; Hannah Gu; Radhika Natarajan; Vijay Sharma
Journal:  Nucl Med Commun       Date:  2014-10       Impact factor: 1.690

Review 9.  Linker Domains: Why ABC Transporters 'Live in Fragments no Longer'.

Authors:  Robert C Ford; Dominic Marshall-Sabey; John Schuetz
Journal:  Trends Biochem Sci       Date:  2019-12-12       Impact factor: 13.807

10.  YQ36: a novel bisindolylmaleimide analogue induces KB/VCR cell death.

Authors:  Ji Cao; Lei Zhang; Qing Ye; Xinglu Zhou; Jianshu Lou; Difeng Zhu; Yongzhou Hu; Qiaojun He; Bo Yang
Journal:  J Biomed Biotechnol       Date:  2010-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.